RCKT ROCKET PHARMACEUTICALS, INC.

NEUTRAL Impact: 3/10 Insider Cluster (3 insiders)
Horizon days Filed May 26, 2026 Processed 19d 12h ago
Insider cluster: 3 insiders, $0.2M total
Latest settled — T+5d
RCKT ▼ -2.34% at T+5d
NEUTRAL call ✗ call lost -2.34% · α vs SPY -2.81% · entry $2.99 → $2.92
Next anchor: T+20d in 9d
Last close $2.75 (close Jun 12) · -8.03% from $2.99 entry
Entry anchored
May 26, 2026
via day open
T+1d
+1.00%
call +1.00% · α +0.45%
$3.02
settled 19d ago
T+5d
-2.34%
call -2.34% · α -2.81%
$2.92
settled 13d ago
T+20d
call — · α —
in 9d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

CEO Gaurav Shah exercised 76,490 options at $1.69 and immediately sold 55,684 shares on the open market for ~$172K, a classic cashless exercise pattern. Two other executives sold small amounts ($1K-$2K) at $3.01. Total cluster sales of $175K represent ~0.05% of market cap — trivial in size. The CEO's sale is likely liquidity-driven (tax withholding or diversification) rather than a bearish signal, especially given the small dollar amount relative to market cap.

Key Financial Metrics

Direction
selling
Total Value
$175.0K
Insiders
3

Actionable Insight

This cluster is routine and non-informative. The CEO's cashless exercise is standard post-vesting liquidity management. With only 0.05% of market cap sold and no C-suite cluster buying, there is no actionable signal. Monitor for any upcoming material news (earnings, pipeline updates) that could explain the timing, but the dollar amounts are too small to warrant a trade.

Key Facts

  • CEO Gaurav Shah exercised 76,490 options at $1.69 and sold 55,684 shares at $3.09 for ~$172K on 2026-05-21
  • Two other executives (John Militello, Martin Wilson) sold 384 and 662 shares respectively at $3.01 for ~$1K each
  • Total cluster sale value of ~$175K is 0.05% of $323M market cap — well below the 0.1% materiality threshold
  • CEO's sale is a cashless exercise pattern (exercise + immediate sale to cover cost/taxes) — not a directional bearish signal
  • No open-market purchases in the cluster; all three transactions are sales

Financial Impact

Total insider sales of ~$175K, representing 0.05% of market cap — immaterial

insider holdingsdilution

Risk Factors

  • CEO's option exercise adds 76,490 shares to the float, but this is minimal dilution (~0.1% of shares outstanding)
  • No insider buying to offset the sales — consistent with a neutral stance, not bearish

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
55% bullish (20 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-RCKT-1779839259223
5 reports for RCKT
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for RCKT — sortable, filterable
Type Now
Jun 12, 2026
3d ago
8-K
BULLISH ★ 5/10
$2.77 awaiting T+5awaiting T+5$2.75 (−0.72%)
May 26, 2026
19d ago
Insider Cluster
NEUTRAL ★ 3/10
$2.99 $2.92▼ −2.34%▼ −2.81%$2.75 (−8.03%)
May 7, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$3.25 $2.96▼ −8.92%▼ −9.89%$2.75 (−15.38%)
Mar 11, 2026
13w ago
EFFECT
NEUTRAL ★ 4/10
$4.96 $4.47▼ −9.88%▼ −7.69%$2.75 (−44.56%)
Mar 2, 2026
14w ago
S-3
BEARISH ★ 7/10
$4.80 $5.30▼ −10.42%▼ −10.89%$2.75 (+42.71%)
Showing 5 of 5

US Market Status

Market Closed — Opens in 1h 40m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access